Danièle Guyot-Caparros
Director/Board Member at DBV TECHNOLOGIES
Network origin in Danièle Guyot-Caparros first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 19 | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products.
11
| Subsidiary | Chemicals: Specialty | 11 |
| Subsidiary | Medical Specialties | 6 | |
| Public Company | Medical Specialties | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Danièle Guyot-Caparros via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the company is based in Antony, France. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
| SENSORION | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin | |
| NOVARTIS AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| NANOBIOTIX | Medical Specialties | Chairman Director/Board Member | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Chief Tech/Sci/R&D Officer Chairman | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INSULET CORPORATION | Medical Specialties | Director/Board Member Corporate Secretary | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| STALLERGENES | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Chairman Chairman | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Solvay France SA
 Solvay France SA Chemicals: Major DiversifiedProcess Industries Solvay France SA engages in the production of specialty chemicals. The company was founded in 1863 and is headquartered in Paris, France. | Chemicals: Major Diversified | Director/Board Member General Counsel | |
| Aventis, Inc. | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| UNIQURE N.V. | Biotechnology | Chief Executive Officer Director/Board Member | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| École des Hautes Études Commerciales du Nord | College/University | Graduate Degree Undergraduate Degree | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TIGENIX NV | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Aventis Pharma International SAS | Corporate Officer/Principal Corporate Officer/Principal | ||
| UCB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Arterial Remodelling Technologies SA
 Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree Masters Business Admin | |
| INVENTIVA | Biotechnology | Chief Tech/Sci/R&D Officer | |
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| SOLVAY SA | Chemicals: Specialty | Compliance Officer | |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member | |
Aventis Pharma Ltd.
 Aventis Pharma Ltd. Medical DistributorsDistribution Services Part of Sanofi, Aventis Pharma Ltd. is a British company that engages in the wholesale of pharmaceutical goods. The company is based in Reading, UK. Aventis Pharma was founded in 1980. | Medical Distributors | Corporate Officer/Principal | |
| Université Paris Nanterre | College/University | Graduate Degree | |
| COVIA HOLDINGS CORPORATION | Construction Materials | Director/Board Member |
Statistics
International
| France | 24 |
| United States | 11 |
| Belgium | 6 |
| United Kingdom | 4 |
| Switzerland | 4 |
Sectoral
| Health Technology | 36 |
| Consumer Services | 6 |
| Finance | 3 |
| Process Industries | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 339 |
| Corporate Officer/Principal | 122 |
| Independent Dir/Board Member | 99 |
| Chairman | 98 |
| Chief Tech/Sci/R&D Officer | 46 |
Most connected contacts
| Insiders | |
|---|---|
| Per Anders Göte Samuelsson | 36 |
| Bo Jesper Hansen | 34 |
| Russell Greig | 31 |
| Joseph Zakrzewski | 30 |
| Patricia K. Dolan | 28 |
| Michel de Rosen | 28 |
| Jean-Pierre Kinet | 26 |
| Michel Arié | 25 |
| Jean Bizzari | 24 |
| Didier Hoch | 24 |
| Philippe Boucheron | 24 |
| Patrick J. Langlois | 23 |
| Catherine Dunand | 23 |
| Maïlys Ferrère | 21 |
| Timothy Morris | 21 |
- Stock Market
- Insiders
- Danièle Guyot-Caparros
- Company connections
